feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Wegovy Pill Arrives: Ro Sees Surge in Demand, Defies Stigma

Wegovy Pill Arrives: Ro Sees Surge in Demand, Defies Stigma

28 Jan

•

Summary

  • Ro reports an influx of new customers for the Wegovy pill version.
  • Men are seeking the pill due to convenience and lower introductory price.
  • Ro plans major Super Bowl advertising featuring Serena Williams.
Wegovy Pill Arrives: Ro Sees Surge in Demand, Defies Stigma

Telehealth company Ro has observed a significant increase in new customers seeking the recently introduced pill form of Wegovy for weight loss. This new offering has particularly attracted men who were previously hesitant to use the injection version of the popular drug.

The surge in demand is attributed to the pill's convenience compared to injections and its introductory price of $149 per month. Patients can access the drug for $149 to $299 monthly, with this pricing available through mid-April. Insured patients may pay less.

Wegovy, based on semaglutide, mimics a gut hormone to suppress appetite and promote satiety. Launched on January 5, it is the sole GLP-1 pill currently approved for weight loss, with a competing pill from Eli Lilly expected to receive FDA review in April.

trending

Vodafone Idea turnaround plan

trending

Dixon Tech share price rises

trending

South Indian Bank shares tank

trending

Gold, silver prices jump

trending

Sabalenka, Rybakina Australian Open Final

trending

RCB wins WPL match

trending

Realme P4 Power launched

trending

Swiggy share price declines

trending

Quartararo leaving Yamaha for Honda

Ro is preparing a major advertising push for the Super Bowl, including a commercial starring Serena Williams. This campaign, part of the 'Healthier on Ro' initiative, aims to highlight broader health benefits beyond weight management and challenge the stigma surrounding GLP-1 drugs, portraying them as a tool for lazy individuals.

The Super Bowl, a highly-watched U.S. television event, serves as a prime advertising platform. An estimated 100 million viewers tune in annually, with 30-second ad slots costing approximately $8 million.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Ro is offering the newly launched pill version of Wegovy, which is approved for weight loss and uses the active ingredient semaglutide.
The introductory price for the Wegovy pill through Ro is $149 per month for the lowest dose, with higher doses costing up to $299 per month.
Ro is planning a significant advertising campaign for the Super Bowl, featuring tennis star Serena Williams, to combat stigma and highlight the drug's benefits.

Read more news on

Healthside-arrow

You may also like

Bud Light Unleashes Hilarious Wedding Mayhem in Super Bowl Ad

10 mins ago

article image

Patriots QB Drake Maye's Injury Revealed Before Super Bowl

1 day ago • 9 reads

article image

NFL's Future Stars Unveiled: Top 100 Players Ranked

27 Jan • 56 reads

article image

Adams Claps Back: Maye Haters Told Off!

28 Jan • 13 reads

article image

London Returns: Fantasy Star Ready for Week 17 Bounce Back

25 Dec, 2025 • 158 reads

article image